In primary human lung carcinomas, IL-17 was linked to the cancer cell production of a variety of pro-angiogenic factors, such as IL-6, IL-8, and VEGF (132), as well as to the upregulation of VEGF-C, a growth factor involved in lymphangiogenesis (133). Here, VEGFA is linked to cancer.